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OBJECTIVES We aimed to investigate the determinants of left atrial (LA) volume and its prognostic value
in patients with dilated cardiomyopathy (DCM).
BACKGROUND Enlargement of the LA is a marker of mortality in the general population. Patients with
DCM are characterized by a wide range of LA sizes, but the clinical role of this observation
has been played down.
METHODS A complete echocardiographic Doppler examination was performed in 337 patients (age 60
 13 years; 84% male) with the diagnosis of DCM. Left atrial maximal volume (LAmax) was
measured at left ventricular (LV) end systole (four-chamber view; area–length method). Left
ventricular end-diastolic and end-systolic volumes (LVEDV and LVESV) and ejection
fraction (EF) were also measured. Mitral regurgitation (MR) was graded using a 5-point
scale. Mitral E-wave (E) and A-wave (A) velocities, as well as their ratio (E/A), were
measured off-line.
RESULTS Determinants of LAmax were: atrial fibrillation (r  0.34, p  0.0001), LVEDV (r  0.46,
p  0.0001), EF (r  0.40, p  0.0001), MR (r  0.39, p  0.0001), and E/A ratio (r 
0.36, p  0.0001). During follow-up (41  29 months), 77 patients died and 12 underwent
heart transplantation. Univariate Cox analysis showed that LAmax (hazard ratio [HR] 1.01,
95% confidence interval [CI] 1.007–1.013, p  0.0001), LVESV (HR 1.003, CI 1.001–
1.005, p  0.0003), E/A ratio (HR 1.6, CI 1.3–2.005, p  0.0001), and MR (HR 1.21, CI
1.03–1.44, p  0.02) were related to the outcome. On bivariate Cox analysis, LAmax
predicted the prognosis independently of each determinant. Patients with a larger LA volume
(LAmax/m
2 68.5 ml/m2) had a risk ratio of 3.8 compared with those with a smaller LA
volume.
CONCLUSIONS In patients with DCM, LA volume is associated with LV remodeling, diastolic dysfunction,
and the degree of MR. The maximal volume of the LA has an independent and incremental
prognostic value, compared with all its determinants. (J Am Coll Cardiol 2002;40:1425–30)
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In patients with dilated cardiomyopathy (DCM), a wide
range of left atrial (LA) sizes has been observed (1,2). The
prognostic impact of this observation has recently been
analyzed in the Studies Of Left Ventricular Dysfunction
(SOLVD) population (3). Patients with a reduced left
ventricular (LV) ejection fraction (EF) had an increased risk
proportional to the increase in the size of the LA, which was
independent of EF, age, or symptomatic status. However, it
is unclear whether the prognostic power of the enlarged LA
might be the result of LV diastolic dysfunction or the
presence of mitral regurgitation (MR) or atrial fibrillation
(AF). This is noteworthy because all of these pathophysio-
logic variables contribute to both enlarging the atrial cham-
ber (4–6) and influencing the prognosis in patients with a
reduced EF (1,2,7,8). Although atrial enlargement has long
been known to be associated with an increased mortality
rate in the general population (9), the pathophysiologic
determinants of atrial size have rarely been investigated,
particularly in patients with ventricular diseases. It has
recently been demonstrated that the size of the LA is better
described by volume rather than diameter (10). However,
unidimensional measurement is still the method used
worldwide to quantify atrial size, so that the potential
clinical information provided by atrial volume is largely
hidden. The aims of the present study were to analyze the
degree of LA remodeling and the pathophysiologic deter-
minants of LA volume in patients with LV systolic dys-
function and to verify the prognostic power of atrial volume
in relation to its determinants.
METHODS
Patients were recruited from those routinely referred to the
Outpatient Clinic of Verona Hospital with a diagnosis of
DCM. Consecutive patients who had a complete echocar-
diographic Doppler examination in the echocardiographic
laboratory of our institution within one month of clinical
evaluation (beginning of follow-up) formed the study pop-
ulation. The exclusion criteria were: 1) significant organic
mitral or aortic valve disease; 2) the presence of clinical or
echocardiographic features of amyloidosis or constrictive
pericarditis; and 3) a recent myocardial infarction (6
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months). The duration of the disease was taken to be the
number of years of awareness of cardiac impairment.
Twenty-six gender- and age-matched subjects in sinus
rhythm, with no history of cardiac disease and with entirely
normal echocardiographic findings, who had been referred
to the echocardiographic laboratory to rule out pericardial
disease or for systolic murmurs, were enrolled as a control
group.
Follow-up information was obtained from clinical
records, death certificates, and correspondence. The com-
posite end point of follow-up was death or heart transplan-
tation. Patients who died of noncardiac causes were cen-
sored at the time of death.
Echocardiography. Left atrial maximal volume (LAmax)
was measured at LV end systole, and LA minimal volume
(LAmin) at LV end diastole from the apical four-chamber
view (area–length method). Left ventricular end-diastolic
and end-systolic volumes (area–length method) and EF
were measured off-line from the apical four-chamber view.
Mitral E-wave (E) and A-wave (A) velocities, E/A ratio,
and E-wave deceleration time (DTE) were also measured
off-line. This last variable was measured as the interval (in
milliseconds) from peak early mitral filling to an extrapola-
tion of the deceleration to 0 m/s. All measurements were
obtained from the mean of 3 beats for patients in sinus
rhythm and 5 beats for those with AF. A restrictive mitral
inflow pattern was defined as an E/A 2 or between 1 and
2 and DTE 140 ms in patients in sinus rhythm or a DTE
140 ms in patients with AF. Mitral regurgitation was
semiquantitatively assessed by color flow Doppler echocar-
diography. Five regurgitant grades were routinely deter-
mined and recorded directly in the study data base (0  no
regurgitation; 1  mild; 2  mild to moderate; 3 
moderate; 4  moderate to severe; 5  severe).
Statistical analysis. Continuous data are presented as the
mean value  SD. Comparisons of all measurements
between normal subjects and patients with DCM were
made using the unpaired t test. Determinants of LAmax
were evaluated using linear regression analysis. Multivariate
analysis was used to identify the independent relationship
between each variable and LA volume. Ejection fraction was
not used in the multivariate model, so as to avoid multi-
collinearity, because it is both statistically and pathophysi-
ologically related to left ventricular end-diastolic and end-
systolic volume (LVEDV and LVESV). The E-wave DT
and velocity were also not used in the model because of their
strong relation to the E/A ratio. The relation of specific
variables to mortality was investigated univariately using the
Cox proportional hazards model. To assess the indepen-
dence of the predictive value of LAmax from that of its
determinants, bivariate models were used.
The prognostic power of LA parameters (LAmax, LAmax/
m2, LAmin, LAmin/m
2) significantly related to the outcome
was compared using the log-likelihood ratio test.
Receiving-operator characteristics (ROC) curves were
constructed to compare different predictive values at partic-
ular time points. Differences between curves were assessed
with the z-statistic. The best prognostic cut-off value for
survival status, defined as that which gave the highest
product of sensitivity and specificity, was used to dichoto-
mize patients for Kaplan-Meier survival analysis. To per-
form these analyses, two different statistical programs were
employed: Statview 5.0 (Abacus Concepts, SAS Institute,
Cary, North Carolina) and MedCalc 5.0 (Mariakerke,
Belgium). A p value 0.05 was considered statistically
significant.
RESULTS
A total of 337 patients (294 men and 43 women; age 60 
13 years) formed the study population. Table 1 shows the
clinical and echocardiographic characteristics of the pa-
tients. The etiology of their cardiomyopathy was idiopathic
in 25% and ischemic in the remaining 75%.
Left atrial remodeling and determinants of LA volume.
Patients with DCM showed a larger LAmax (131 [SD] 65
ml, SEM 4.1; range 25 to 481) compared with normal
control subjects (59  [SD] 19 ml, SEM 3.8; p  0.0001);
however, a wide range was observed. The frequency of LA
remodeling was high: 75% of patients with DCM had a
Abbreviations and Acronyms
AF  atrial fibrillation
CI  confidence interval
DCM  dilated cardiomyopathy
EF  ejection fraction
HR  hazard ratio
LA  left atrium/atrial
LV  left ventricle/ventricular
LVEDV and LVESV  left ventricular end-diastolic and
end-systolic volume, respectively
MR  mitral regurgitation
ROC  receiver-operating characteristic
Table 1. Clinical and Echocardiographic Characteristics of 337
Patients With Dilated Cardiomyopathy
Variable Mean  SD
Age (yrs) 60  13
AF (%) 12
NYHA functional class 2.3  0.4
LAmax (ml) 131  65
LAmax/m
2 (ml/m2) 70  35
LVEDV (ml) 315  120
LVESV (ml) 227  112
EF (%) 31  9
E (m/s) 0.6  0.3
E/A ratio 1.2  0.9
DTE (ms) 200  75
Restrictive mitral pattern (%) 22
MR grade 1.4  1.3
LV mass (g) 386  119
AF  atrial fibrillation; DTE  E-wave deceleration time; E  mitral E-wave
velocity; E/A  early mitral to atrial flow velocity ratio; EF  ejection fraction;
LAmax  left atrial maximal volume; LV  left ventricular; LVEDV  left
ventricular end-diastolic volume; LVESV  left ventricular end-systolic volume;
MR  mitral regurgitation; NYHA  New York Heart Association.
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LAmax higher (by 1 SD of the mean value) than that of
control subjects. In contrast, no differences in the E-wave
velocity (0.61  [SD] 0.2, SEM 0.015 vs. 0.64  [SD] 0.2,
SEM 0.04; p  0.6), A-wave velocity (0.59  [SD] 0.3,
SEM 0.015 vs. 0.67  [SD] 0.2, SEM 0.039; p  0.08),
E/A ratio (1.19  [SD] 0.9, SEM 0.060 vs. 0.98  [SD]
0.3, SEM 0.058; p  0.2), or DTE (200  [SD] 75, SEM
4.86 vs. 215  [SD] 47, SEM 9.4; p  0.3) were observed
between patients and control subjects. The determinants of
LA volume were defined by means of linear regression
analysis (Table 2).
The LAmax increased with LV enlargement, increasing
severity of MR, degree of diastolic dysfunction, and pres-
ence of AF. Multivariate analysis showed that LAmax was
independently related to age and the degree of MR and more
strongly related to the LVEDV and E/A ratio (Table 3).
In 102 patients for whom the duration of the disease was
available, LAmax normalized by body surface area (LAmax/
m2) showed a positive relation to the duration of the disease
(p  0.007), independently of age (p  0.0005), in a
multivariate model.
Survival analysis. During follow-up (median 41  29
months), 77 patients died and 12 underwent heart trans-
plantation. Five patients died of noncardiac causes and,
accordingly their follow-up, were censored at the time of
death. Cox univariate analysis showed several clinical and
echocardiographic markers of prognosis in our population
(Table 4). The maximal volume of the LA was a strong
predictor of mortality (hazard ratio [HR] 1.01, 95% confi-
dence interval [CI] 1.007 to 1.013; p  0.0001). However,
most of the variables identified as determinants of LAmax—
namely, ventricular volumes, MR, and markers of diastolic
function—showed clinically important predictive power, as
well.
Bivariate Cox models were subsequently used to assess
the independence of the prognostic value of LAmax from
that of each of its determinants (Table 5). Bivariate analysis
was preferred to avoid multi-collinearity, because most of
the determinants of LAmax are strongly related to each
other.
Although the presence of AF did not influence the
prognosis in our population, we performed a subgroup
analysis of patients with chronic AF. This group consisted
of 39 patients (mean age 63  8 years, mean EF 26  9%)
who were followed up for 51 29 months; 14 patients died.
In this group, LAmax maintained its predictive power (HR
1.01, CI 1.003 to 1.018; p  0.008), but EF did not have
any impact on the prognosis. Likewise, the predictive value
of LAmax was confirmed in patients without MR (grade1)
(HR 1.01, CI 1.006 to 1.017; p  0.0001) and with MR
(HR 1.008, CI 1.004 to 1.013; p  0.0008).
When the overall population was classified into two
groups according to the presence or absence of a restrictive
Table 2. Echocardiographic Determinants of Left Atrial
Maximal Volume in the Study Population (Univariate Analysis)
Variable r p Value
AF 0.34  0.0001
LVEDV (ml) 0.46  0.0001
LVESV (ml) 0.45  0.0001
EF (%) 0.40  0.0001
E (m/s) 0.30  0.0001
E/A ratio 0.36  0.0001
DTE (ms) 0.32  0.0001
MR grade 0.39  0.0001
LV mass (g) 0.29 0.0002
Abbreviations as in Table 1.
Table 3. Echocardiographic Determinants of Left Atrial Maximal





E/A ratio  0.0001
LVEDV (ml) 0.0004
LVESV (ml) 0.9
Abbreviations as in Table 1.
Table 4. Predictors of Death in the Study Population (Cox
Univariate Analysis)
Variable p Value HR (95% CI)
NYHA functional class  0.0001 2.05 (1.46–2.88)
Age (yrs) 0.005 1.03 (1.01–1.057)
AF 0.5 0.8 (0.5–1.42)
LAmax (ml)  0.0001 1.01 (1.007–1.013)
LAmax/m
2 (ml/m2)  0.0001 1.02 (1.015–1.026)
LAmin (ml)  0.0001 1.01 (1.006–1.013)
LAmin/m
2 (ml/m2)  0.0001 1.02 (1.01–1.03)
LVEDV (ml) 0.001 1.003 (1.001–1.005)
LVESV/m2 (ml/m2) 0.0001 1.006 (1.003–1.009)
LVESV (ml) 0.0003 1.003 (1.001–1.005)
LVESV/m2 (ml/m2)  0.0001 1.007 (1.003–1.010)
EF (%) 0.0006 0.96 (0.93–0.98)
E/A ratio  0.0001 1.6 (1.28–2.005)
Restrictive mitral pattern  0.0001 0.33 (0.20–0.55)
MR grade 0.02 1.21 (1.028–1.44)
CI  confidence interval; HR  hazard ratio; LAmin  left atrial minimal volume;
other abbreviations as in Table 1.
Table 5. Predictors of Death in the Study Population (Cox
Bivariate Models)
Model Variable p Value HR
1 LAmax (ml)  0.0001 1.009 (1.006–1.013)
Age (yrs) 0.02 1.03 (1.005–1.057)
2 LAmax (ml)  0.0001 1.008 (1.005–1.012)
LVESV (ml) 0.1 1.002 (1.00–1.004)
3 LAmax (ml)  0.0001 1.008 (1.005–1.012)
EF (%) 0.08 0.97 (0.95–1.003)
4 LAmax (ml)  0.0001 1.008 (1.004–1.012)
Restrictive mitral pattern 0.3 0.7 (0.38–1.31)
5 LAmax (ml)  0.0001 1.010 (1.005–1.015)
E/A ratio 0.3 1.20 (0.87–1.65)
6 LAmax (ml)  0.0001 1.009 (1.005–1.014)
MR grade 0.8 1.029 (0.84–1.26)
Abbreviations as in Table 1.
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mitral filling pattern, LAmax significantly predicted the
outcome in both groups (HR 1.006, CI 1.001 to 1.012, p
0.03 and HR 1.01, CI 1.005 to 1.017, p  0.0003,
respectively).
The log-likelihood ratio test showed that LAmax/m
2 was
a more powerful predictor of survival than LAmax (p 
0.0001), LAmin (p  0.0001), and LAmin/m
2 (p  0.02).
The best cut-off value for LAmax/m
2 in the overall
population, regardless of the duration of follow-up, was
calculated using ROC analysis. The value of 68.5 ml/m2
predicted survival with 65% sensitivity (95% CI 55.8 to
73.9) and 76% specificity (CI 65.6 to 88.4). Patients with a
higher LAmax/m
2 value had a 3.8 times higher risk of an
adverse outcome than patients with a smaller LA. The
ROC area under the curve (AUC) for LAmax/m
2, as a
continuous variable, was higher than that for LVESV/m2
over the whole follow-up period, reaching statistical signif-
icance at 12 months (p  0.009) (Fig. 1).
Kaplan-Meier curves were constructed using a cut-off
value for LAmax/m
2 of 68.5 ml/m2. Survival analysis was
performed for the subgroup of patients with particularly
severe systolic dysfunction (EF 30%). The presence of a
large LA volume predicted a worse outcome, compared with
patients with a smaller LA (Fig. 2).
DISCUSSION
The present study showed that LA remodeling is frequent,
in patients with DCM. Left atrial volume is mainly deter-
mined by the degree of LV dilation, diastolic dysfunction,
and the extent of MR. On survival analysis, LA volume is
found to be a powerful prognostic marker, adding important
clinical information, independent of any of its determinants.
In patients with chronic heart failure due to DCM,
diastolic dysfunction is an important hallmark of the sever-
ity of the disease. The degree of diastolic impairment
correlates with symptoms and prognosis more closely than
does EF (1,2,11–13). However, the predictive power of
diastolic markers has been frequently but not uniformly
confirmed (14). This is probably due to the strong load
dependency of mitral parameters, which can dramatically
change after blood volume depletion (15). It has been shown
that the predictive power of mitral inflow can be enhanced
when analyzed in relation to loading modification (16). The
role of LA size as a diastolic marker is well known (17–19),
and, accordingly, we found a strong relation between atrial
volume and diastolic markers. Interestingly, the predictive
value of atrial volume is stronger and independent of
echocardiographic Doppler diastolic parameters. This
might be related to a lower load dependency due to
increased fibrosis and reduced elastic recoil in a chronically
enlarged atrium (20–22). Furthermore, LA size has been
shown to reflect prognosis in patients who have cardiac
disease with prevalent diastolic function, such as aortic
stenosis and restrictive cardiomyopathy (23–25).
Functional MR is a major confounding factor in the
hemodynamic of patients with LV systolic dysfunction
Figure 1. The receiver-operating characteristic (ROC) areas under the
curve (AUC) of left atrial maximal volume/m2 (line with triangles) and
left ventricular end-systolic volume/m2 (line with squares) of patients with
dilated cardiomyopathy for prediction of death at 12 to 72 months.
Figure 2. Kaplan-Meier survival curves of a subgroup of patients with severe systolic dysfunction (ejection fraction 30%), taken from the overall study
population and classified into two groups according to the best cut-off value of left atrial maximal volume (LAmax)/m
2 (68.5 ml/m2), as obtained from the
receiver-operating characteristic curves (see text for details).
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(26,27). Mitral regurgitant volume is a key determinant of
atrial volume (5), which may reflect the severity, duration,
and prognosis of MR (28). However, in our study, the
predictive role of LA volume proved to be more powerful
than MR, independent of the degree of MR, and it was
confirmed in both the group of patients with and the group
without MR.
The relationship between atrial dilation, AF, and LV
dysfunction is intriguing, and it may contribute to overshad-
owing of the predictive power of atrial size. However, in our
study, AF had no prognostic power, and, more interestingly,
the predictive value of LA volume was confirmed in the
subgroup of patients with AF.
In our opinion, LA enlargement represents a strong
predictive marker, because the atrial chamber is a window
allowing comprehensive evaluation of several factors associ-
ated with a bad prognosis, which are often difficult to
document separately. Atrial size might also reflect marked
hemodynamic atrial overload in specific phases during the
course of chronic heart disease, such as during exercise,
giving evidence of temporal hemodynamic impairment (MR
or diastolic dysfunction) which otherwise would remain
silent (29). An appealing suggestion is that LA volume
stores information on the history of the disease (30),
highlighting its duration (31). Accordingly, in our study,
LA volume correlated weakly but significantly with the
duration of the disease.
These observations might help to explain the difference in
AUCs between atrial and ventricular volumes in short-term
follow-up (12 months). The low predictive value of
LVESV/m2 at this time point might depend on improve-
ment of LV function, which, in some cases, occurs sponta-
neously (32) or after pharmacologic or surgical therapy in
the early phase of the disease. The excellent prognosis
associated with ventricular recovery (32) might confound
the predictive power of the dysfunctional ventricle at base-
line.
It is possible that in patients with DCM, atrial enlarge-
ment could also be due to concomitant atrial myopathic
disease (33) caused by a more widespread primary patho-
logic process. Finally, the prognostic role of LA size might
be partly related to natriuretic peptide levels (e.g., atrial
natriuretic peptide) (34), which have been demonstrated to
have diagnostic (35) and prognostic power (36) in patients
with LV systolic dysfunction.
Others studies have included LA size in the survival
analysis. In particular, two studies (1,2) showed that LA size
predicted the outcome independent of the restrictive mitral
pattern, New York Heart Association functional class and
EF, but they confirmed that the restrictive pattern had a
higher predictive power than did atrial size. A possible
explanation might be the difference between their patient
cohorts and ours. Both studies analyzed populations of
patients with very severe diastolic dysfunction, with a
prevalence of a restrictive pattern of 42% and 46%, respec-
tively. The narrow range of these pathophysiologic variables
raises the question as to whether those cohorts can ade-
quately represent the whole spectrum of the disease. In
contrast, our population was characterized by a wider range
of systolic dysfunction, and only a 22% prevalence rate of a
restrictive pattern, indicating a less severe disease state.
Furthermore, in the study by Pinamonti et al. (2), the
overall population had a relatively young mean age (39 15
years). This casts doubt on the accuracy of mitral parameters
in describing restrictive physiology, because of the strong
age dependence of the mitral pattern.
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